449.90USD+0.36%Mkt Cap: 166.94B USDP/E: 24.68Last update: 2026-05-26
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationall…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap166.94B USD
Enterprise Value207.03B USD
Revenue (TTM)45.20B USD
Gross Profit18.24B USD
Net Income (TTM)6.70B USD
Revenue/Share120.36 USD
Last Price449.90 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees125.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS8835561023
Valuation
P/E (Trailing)24.68
P/E (Forward)16.46
PEG1.49
EV/EBITDA18.33
EV/Revenue4.58
P/S3.69
P/B3.17
EPS (TTM)18.20
EPS (Forward)27.30
52W Range
385.4625% of range643.99
52W High643.99 USD
52W Low385.46 USD
Profitability
Gross Margin40.93%
Oper. Margin17.89%
EBITDA Margin24.99%
Profit Margin15.05%
ROE12.55%
ROA6.08%
Growth
Revenue Growth6.20%
Earnings Growth11.30%
Cash Flow & Leverage
Operating CF7.82B USD
CapEx (TTM)1.52B USD
FCF Margin12.21%
FCF Yield3.31%
Net Debt39.91B USD
Net Debt/EBITDA3.53
Balance Sheet
Debt/Equity0.74
Current Ratio1.53
Quick Ratio0.97
Book Value/Sh141.96 USD
Cash/Share8.762 USD
Dividends
Fwd Div Rate1.880 USD
Trail. Div Rate1.760 USD
Div. Yield0.42%
5Y Avg Yield0.25%
Payout Ratio9.68%
Ex-Div DateJun 15, 2026
Pay DateApr 15, 2026
Splits
Last Split3:2
Split DateJun 6, 1996
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)611.56 USD
Target Range490.00 USD – 750.00 USD
# Analysts25
Ownership
Shares Out.371.62M
Float370.67M
Insiders0.15%
Institutions94.33%
Short Interest
Short Ratio2.4d
Short % Float1.31%
Short % Out.1.31%
Shares Short4.87M
Short (prev mo.)4.07M
Technical
SMA 50479.91 (-6.3%)
SMA 200526.64 (-14.6%)
Beta0.88
S&P 52W Chg28.31%
Avg Vol (30d)2.34M
Avg Vol (10d)2.80M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—